Shock Drugs Flashcards

1
Q

first line for shock

A

dopamine and norepinephrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

dopamine dosing

A

1-3 mcg/kg/min
3-10 mcg/kg/min
10-20 mcg/kg/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

low dopamine dosing receptors

A

mainly DA

some B1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

low dopamine MOA

A

vasodilation of arteries (renal, mesenteric, cerebral, and coronary)
natriuretic response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

low dopamine monitoring

A

evidence does not support use for renal protection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

med dose dopamine receptors

A

mostly B1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

med dose dopamine MOA

A

increase contractility and HR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

med dose dopamine monitoring

A

can induce tachyarrhythmias

may complement vasoconstrictive effects of NE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

high dose dopamine receptors

A

mostly a1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

high dose dopamine moa

A

increase SVR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

high dose dopamine monitoring

A

renal blood flow effects lost

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

NE dosing

A

2-20 mcg/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

NE receptors

A

mostly a1

some b1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

NE moa

A

increase SVR

small increase in HR and contractility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

NE monitoring

A

decrease renal perfusion

CO and LV function decrease at high doses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Epi dosing

A

1-10 mcg/min

17
Q

epi receptors

A

works in both a1 and b1

18
Q

epi moa

A

increases SVR, HR, and contractility

19
Q

epi monitoring

A

watch for tachyarrhythmias

20
Q

phenylephrine dosing

A

30-300 mcg/min

21
Q

PE receptors

22
Q

pe moa

A

increased svr

23
Q

pe monitoring

A

minimal cardiac activity

preferred in patients w history of arrhythmias

24
Q

vaso dosing

A

0.03-0.04 units/min

25
vaso receptors
NONE
26
vaso moa
non-adrenergic | increases SVR by stimulation of V1 smooth muscle receptors (causes vasoconstriction)
27
vaso monitoring
do not titrate above state dose (too much vasoconstriction) | effective in acidosis and hypoxia
28
dobutamine dosing
2-20 mcg/kg/min
29
dobutamine receptors
mostly b1
30
dobutamine moa
increase HR and CO
31
dobutamine monitoring
primarily used for cardiogenic shock | can induce tachyarrhythmias
32
milrinone dosing
0.35-0.75 mcg/kg/min
33
milrinone receptors
NONE
34
milrinone moa
inhibits PDE in cardiac and vascular tissue decreases preload and afterload which.. increases contractility and CO
35
milrinone monitoring
inodilator renal function should be monitored can cause arrhythmias
36
AT 2 dosing
20-40 ng/kg/min
37
at 2 receptors
NONE
38
at 2 moa
``` causes vasoconstriction increases aldosterone (increases BP) ```
39
at 2 monitoring
thrombotic event | patient should respond within minutes